C2 - complement C2 Gene

Also Known as CO2; ARMD14

Species: Homo sapiens

Gene Type: protein coding
Gene ID: 717

About C2

Cytogenetic location: 6p21.33 Genomic coordinates (GRCh38): 6:31,897,783-31,945,672 (from NCBI)

This gene has 24 transcripts (splice variants), 1 gene allele, 85 orthologues, 39 paralogues and is associated with 3 phenotypes. Biased expression in liver (RPKM 95.8), lung (RPKM 36.7) and 11 other tissues.

Summary

Component C2 is a serum glycoprotein that functions as part of the classical pathway of the Complement System. Activated C1 cleaves C2 into C2a and C2b. The serine proteinase C2a then combines with complement factor 4b to create the C3 or C5 convertase. Deficiency of C2 has been reported to associated with certain autoimmune diseases and SNPs in this gene have been associated with altered susceptibility to age-related macular degeneration. This gene localizes within the class III region of the MHC on the short arm of chromosome 6. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described in publications but their full-length sequence has not been determined.[provided by RefSeq, Mar 2009]

C2 Products (6)

mRNA Protein Name
NM_000063.6 NP_000054.2 complement C2 isoform 1 preproprotein
NM_001145903.3 NP_001139375.1 complement C2 isoform 2 precursor
NM_001178063.3 NP_001171534.1 complement C2 isoform 3
NM_001282457.2 NP_001269386.1 complement C2 isoform 4
NM_001282458.2 NP_001269387.1 complement C2 isoform 5
NM_001282459.2 NP_001269388.1 complement C2 isoform 6 precursor

Gene Ontology

  • Molecular Function
  • Biological Process
Molecular Function GO Annotation Evidence References Source
enables protein binding IPI
IPI: Inferred from physical interaction
25910212 GOA
Biological Process GO Annotation Evidence References Source
involved in complement activation IMP
IMP: Inferred from mutant phenotype
19302245 GOA
involved in positive regulation of apoptotic cell clearance IMP
IMP: Inferred from mutant phenotype
19302245 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

C2 Protein Structure

Sushi

Sushi: Sushi repeat (SCR repeat) (89 - 144)

Sushi

Sushi: Sushi repeat (SCR repeat) (151 - 204)

VWA

VWA: von Willebrand factor type A domain (254 - 452)

Trypsin

Trypsin: Trypsin (473 - 703)

  • 0
  • 200
  • 400
  • 600
  • 752 a.a.
Protein Preferred Names Protein Names

complement C2

  • C3/C5 convertase

C2 Protein-protein interaction Information

Type
Protein Name Protein ID Interactor Interactor Species Interactor ID Detection Method References
Intra
C2 P06681 STOM Homo sapiens P27105
Y2H Prey Pooling
32296183
Intra
C2 P06681 STOM Homo sapiens P27105
Validated Y2H
32296183
Intra
C2 P06681 STOM Homo sapiens P27105
Y2H Array
32296183
Intra
C2 P06681 MUC1 Homo sapiens P15941-11
Y2H Prey Pooling
32296183
Intra
C2 P06681 MUC1 Homo sapiens P15941-11
Validated Y2H
32296183
Intra
C2 P06681 MUC1 Homo sapiens P15941-11
Y2H Array
32296183
Intra
C2 P06681 SLC35C2 Homo sapiens Q9NQQ7-3
Y2H Prey Pooling
32296183
Intra
C2 P06681 SLC35C2 Homo sapiens Q9NQQ7-3
Validated Y2H
32296183
Intra
C2 P06681 SLC35C2 Homo sapiens Q9NQQ7-3
Y2H Array
32296183
Intra
C2 P06681 FAM209A Homo sapiens Q5JX71
Y2H Array
32296183
Intra
C2 P06681 FAM209A Homo sapiens Q5JX71
Y2H Prey Pooling
32296183
Intra
C2 P06681 FAM209A Homo sapiens Q5JX71
Validated Y2H
32296183
Intra
C2 P06681 SEC11C Homo sapiens Q9BY50
Y2H Prey Pooling
32296183
Intra
C2 P06681 SEC11C Homo sapiens Q9BY50
Validated Y2H
32296183
Intra
C2 P06681 SEC11C Homo sapiens Q9BY50
Y2H Array
32296183
Intra
C2 P06681 EBP Homo sapiens Q15125
Validated Y2H
32296183
Intra
C2 P06681 EBP Homo sapiens Q15125
Y2H Array
32296183
Intra
C2 P06681 EBP Homo sapiens Q15125
Y2H Prey Pooling
32296183
Intra
C2 P06681 SLC10A1 Homo sapiens Q14973
Y2H Prey Pooling
32296183
Intra
C2 P06681 SLC10A1 Homo sapiens Q14973
Y2H Array
32296183
Intra
C2 P06681 SLC10A1 Homo sapiens Q14973
Validated Y2H
32296183
Intra
C2 P06681 CREB3 Homo sapiens O43889-2
Y2H Array
25910212
Intra
C2 P06681 CREB3 Homo sapiens O43889-2
Validated Y2H
25910212
Intra
C2 P06681 CREB3 Homo sapiens O43889-2
Y2H Bait-Prey Pool
25910212
Intra
C2 P06681 ERGIC3 Homo sapiens Q9Y282
Y2H Array
32296183
Intra
C2 P06681 ERGIC3 Homo sapiens Q9Y282
Y2H Prey Pooling
32296183
Intra
C2 P06681 ERGIC3 Homo sapiens Q9Y282
Validated Y2H
32296183
Cross: Cross-species interaction Intra: Intraspecies interaction

Recombinant C2 Proteins

Cat. No. Product Name Accession Purity
HY-P74375 C2/Complement C2 Protein, Human (HEK293, His) P06681 (A21-L752) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P74376 C2/Complement C2 Protein, Human (HEK293, Fc) P06681 (A21-L752) ≥ 95%, as determined by reducing SDS-PAGE.

Related Diseases

Diseases Alias
Complement Component 2 Deficiency

  • C2D

  • C2 Deficiency

  • Complement 2 Deficiency

  • Complement Component-2
Macular Degeneration, Age-Related, 14

  • Age Related Macular Degeneration 14

  • ARMD14

  • Macular Degeneration, Age-Related, 14, Reduced Risk Of

  • Macular Degeneration, Age-Related, Type 14
Immunodeficiency Due To A Classical Component Pathway Complement Deficiency

  • Immunodeficiency Due To C1, C4, Or C2 Component Complement Deficiency

  • Immunodeficiency Due To An Early Component Of Complement Deficiency
Retinal Drusen
Eye Disease

  • Eye Diseases

  • Abnormality Of The Eye

  • Toxoplasma Oculopathy
Lupus Erythematosus

  • Lupus

  • Lupus Vulgaris

  • Lupus Erythematosus, Discoid

  • Lupus Erythematosus, Systemic

  • Subacute Cutaneous Lupus

  • Le - [Lupus Erythematosus]
Macular Degeneration, Age-Related, 1

  • Macular Degeneration

  • Age-Related Macular Degeneration

  • Macular Degeneration, Age-Related

  • Age Related Macular Degeneration

  • Age Related Macular Degeneration 1

  • ARMD1

  • Senile Macular Degeneration

  • Maculopathy, Age-Related, 1

  • Macular Degeneration, Age-Related, Reduced Risk Of

  • Age Related Maculopathy 1

  • Age Related Maculopathies

  • Age Related Maculopathy

  • Senile Macular Retinal Degeneration

  • Macular Degeneration Of Retina

  • Age-Related Maculopathy

  • Amd

  • Armd

  • Age-Related Maculopathy, Susceptibility To

  • Maculopathy Age-Related

  • Macular Degeneration, Age-Related, 1, Susceptibility To

  • Maculopathy, Age-Related

  • Macular Degeneration, Age-Related, Type 1

  • Macular Degeneration, Age-Related, 2
Systemic Lupus Erythematosus

  • Lupus Nephritis

  • SLE

  • Disseminated Lupus Erythematosus

  • Systemic Lupus Erythematosus, Susceptibility To

  • Lupus Erythematosus, Systemic

  • Lupus Nephritis, Susceptibility To

  • Libman-Sacks Disease

  • Systemic Lupus Erythematosus Susceptibility To

  • Sle - Lupus Erythematosus, Systemic

  • Le Syndrome

  • Lupus

  • Lupus Erythematosus Systemic

  • Lupus Erythematosus, Systemic, Susceptibility To

  • Lupus Vulgaris

  • Lupus Erythematosus, Discoid

  • Lupus Erythematosus

  • Systemic Lupus Erythematosus Nos

  • Sle - [Systemic Lupus Erythematosus]
Degeneration Of Macula And Posterior Pole

  • Degeneration Of Macula And Posterior Pole Of Retina

  • Degeneration Of Macula Or Posterior Pole

  • Macular Degeneration Nos

  • Degenerative Disorder Of Macula

  • Drusen Macular Degeneration

  • Posterior Pole Macular Degeneration Of Eye

  • Macular Eye Degeneration

  • Macular Degeneration Of Retina, Unspecified

  • Pseudohole Degeneration Of Macula Of Retina
Hemolytic Uremic Syndrome, Atypical 1

  • Atypical Hemolytic-Uremic Syndrome

  • Hemolytic Uremic Syndrome, Atypical, Susceptibility To, 1

  • Atypical Hemolytic Uremic Syndrome

  • Hemolytic Uremic Syndrome, Atypical, Susceptibility To

  • Ahus

  • AHUS1

  • Hemolytic-Uremic Syndrome

  • Ahus 1

  • Ahus, Susceptibility To, 1

  • Hemolytic Uremic Syndrome, Atypical

  • Non-Shiga-Like Toxin-Associated Hus

  • Non-Stx-Hus

  • Nonenteropathic Hus

  • Atypical Hus

  • Shiga Toxin-Associated Hemolytic Uremic Syndrome

  • D+ Hus

  • Ehec-Hus

  • Hemolytic Uremic Syndrome Associated With Shiga Toxin-Producing Escherichia Coli

  • Hemolytic Uremic Syndrome With Diarrhea

  • Stec-Hus

  • Shiga-Like Toxin-Associated Hus

  • Stx-Hus

  • Typical Hus

  • Typical Hemolytic Uremic Syndrome

  • Atypical Hemolytic Uremic Syndrome With Anti-Factor H Antibodies

  • Atypical Hus With Anti-Factor H Antibodies

  • Ahus With Anti-Factor H Antibodies

  • Ahus With Neutralizing Autoantibodies Against Factor H

  • Hemolytic Uremic Syndrome Atypical 1

  • Atypical Hemolytic Uremic Syndrome With H Factor Anomaly

  • D Hus

  • Hemolytic-Uremic Syndrome Without Diarrhea

  • Hemolytic-Uremic Syndrome, Atypical, Type 1

  • Hemolytic Uremic Syndrome, Typical
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0581 Dexrazoxane 99.88% Yes
HY-19806A Ceftolozane sulfate Inhibitor 99.69% Unkown
HY-B1915 Micronomicin Inhibitor 99.92% Unkown
HY-108826 Iduronate sulfatase / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P9913 Rituximab 99.85% Unkown

Clinical Phase

Bioactive Molecules (9)
Cat. No. Product Name Effect
Purity Phase
HY-N0379 D-Mannose ≥98.0% Phase 4
HY-113071A Mevalonic acid lithium salt 99.80% Phase 3
HY-W654136 2'-Deoxycytidine-2'-13C / Phase 3
HY-156701 BAY-1128688 / Phase 2
HY-105277 Amesergide Antagonist / Phase 2
HY-126026 NF-κB-IN-17 Inhibitor / Phase 2
HY-W654098 Cefazolin-13C2,15N sodium Inhibitor / Phase 2
HY-113697 Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD 99.77% Phase 1
HY-N2041S8 Myristic acid-13C2 / Phase 1
Inhibitory Antibodies (2)
Cat. No. Product Name Effect
Purity Phase
HY-P990025 Empasiprubart ≥99.0% Phase 3
HY-P99163 Tilavonemab Inhibitor 99.59% Phase 2

Pre-clinical Phase

Bioactive Molecules (1082)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-142979 DSPE-PEG 2000 99.95% Unkown
HY-N0155 Nobiletin 99.79% Unkown
HY-N0376 Liquiritin 99.99% Unkown
HY-W021401 Amino-PEG3-C2-Azido 98.96% Unkown
HY-101180 C2 Ceramide 99.85% Unkown
HY-140213 Azido-PEG2-C2-amine 99.85% Unkown
HY-130109 N3-PEG4-C2-NHS ester 98.94% Unkown
HY-40171 NH2-C2-NH-Boc 99.52% Unkown
HY-42776 NH2-PEG3-C2-NH-Boc 99.88% Unkown
HY-111152 ML115 Agonist 99.98% Unkown
HY-W007596 Tris(2-phenylpyridinato-C2,N)iridium(III) 99.76% Unkown
HY-128834 N3-PEG4-C2-NH2 ≥98.0% Unkown
HY-140452 Azido-PEG2-C2-acid 99.88% Unkown
HY-100594 EUK-134 Inhibitor 98.27% Unkown
HY-W008474 Boc-NH-PEG2-C2-NH2 99.38% Unkown
HY-130485 Bromo-PEG2-C2-azide 98.70% Unkown
HY-140941 Biotin-PEG2-C2-iodoacetamide 98.23% Unkown
HY-130653 Azido-PEG4-C2-acid 99.20% Unkown
HY-D0187S L-Glutathione reduced-13C2,15N Inhibitor ≥99.99% Unkown
HY-150644 S07-2010 98.35% Unkown
HY-126526 N3-PEG2-C2-NHS ester ≥98.0% Unkown
HY-150795 SY-LB-35 99.54% Unkown
HY-164367 Mal-Bal-Ph(β-D-Glucose)-7-MAD-MDCPT 99.06% Unkown
HY-126528 N3-PEG3-C2-NHS ester 99.94% Unkown
HY-156406 PITCOIN4 Inhibitor 99.97% Unkown
HY-N0322S5 Cholesterol-13C2 Agonist 99.76% Unkown
HY-W015088 Amino-PEG3-C2-Amine 99.78% Unkown
HY-112820 Chlorantraniliprole 98.05% Unkown
HY-Y0966S3 Glycine-13C2 99.88% Unkown
HY-160109 Ac5GalNTGc 98.54% Unkown
HY-W749209 Acetic acid-13C2 sodium 99.7% Unkown
HY-112452 SU11652 99.18% Unkown
HY-112821 IBS008738 98.22% Unkown
HY-135804 NH2-PEG3-C2-Boc 97.0% Unkown
HY-B0351S1 Taurine-13C2 Inducer 99.91% Unkown
HY-126520 N3-C2-NHS ester 99.77% Unkown
HY-162809 XMU-MP-9 99.12% Unkown
HY-22335 Amino-PEG4-C2-amine 98.0% Unkown
HY-W092043 TLR4-IN-C34-C2-COOH Inhibitor 99.94% Unkown
HY-N0602 Ginsenoside Rg2 Inhibitor 98.71% Unkown
HY-42149 NH2-PEG2-C2-Boc ≥98.0% Unkown
HY-W022240 NH2-PEG5-C2-NH-Boc 95.0% Unkown
HY-112599B Pomalidomide-PEG4-C2-NH2 hydrochloride 98.18% Unkown
HY-137320 diABZI-C2-NH2 Agonist 96.14% Unkown
HY-140009 Azido-PEG1-C2-acid 98.0% Unkown
HY-141364 Bromo-PEG1-C2-Boc 98.58% Unkown
HY-130549 Acid-PEG3-C2-Boc 97.0% Unkown
HY-141365 Bromo-PEG2-C2-Boc 97.0% Unkown
HY-40145 1-Boc-3-iodoazetidine 99.79% Unkown
HY-124569 NAB-14 Antagonist 99.44% Unkown
HY-B1337S5 Choline-13C2 chloride 98.8% Unkown
HY-126949 Aminooxy-PEG3-azide 98.0% Unkown
HY-147007 β-catenin-IN-3 Inhibitor 95.64% Unkown
HY-N0543S Allantoin-13C2,15N4 99.90% Unkown
HY-W040168 Amino-PEG2-C2-acid 99.72% Unkown
HY-163084 HJ445A 98.02% Unkown
HY-23167 Acid-PEG4-C2-Boc 99.70% Unkown
HY-W017970 Boc-C2-NH2 99.78% Unkown
HY-Y0262S1 Oxalic acid-13C2 99.45% Unkown
HY-119678 Fortunellin Activator 98.31% Unkown
HY-130483 Br-PEG3-C2-Boc 98.0% Unkown
HY-N4150 Quercetagitrin Inhibitor 98.33% Unkown
HY-P10655 Caloxin 1C2 Inhibitor 99.47% Unkown
HY-W040165 Amino-PEG3-C2-acid 99.94% Unkown
HY-107452 SLF-amido-C2-COOH 99.89% Unkown
HY-126688 Mal-C2-Gly3-EDA-PNU-159682 93.43% Unkown
HY-130815A MAK683-C2-acid hydrochloride Inhibitor 99.60% Unkown
HY-B0351S2 Taurine-13C2,15N Inducer 98.8% Unkown
HY-N1517 Ganoderic acid C2 99.72% Unkown
HY-125843 Pomalidomide-PEG1-C2-N3 99.91% Unkown
HY-167710 CRCD2 99.02% Unkown
HY-126512 Propargyl-C2-NHS ester 97.0% Unkown
HY-130315 Br-PEG4-C2-Boc 98.0% Unkown
HY-140127 Azide-C2-SS-C2-biotin 99.84% Unkown
HY-140585 N-DBCO-N-bis(PEG2-C2-NHS ester) ≥96.0% Unkown
HY-147025 (S,R,S)-AHPC-C2-amide-benzofuranylmethyl-pyridine 98.62% Unkown
HY-W039168 Bromo-PEG3-C2-acid ≥97.0% Unkown
HY-W021402 Fmoc-NH-PEG2-C2-NH2 hydrochloride / Unkown
HY-129703B Thalidomide-PEG2-C2-NH2 hydrochloride Inducer 99.93% Unkown
HY-141362 Bromo-PEG2-C2-acid 99.73% Unkown
HY-W371165 C1s-IN-1 trihydrochloride Inhibitor 99.73% Unkown
HY-W749251 5-Aminolevulinic acid-13C2,15N hydrochloride 99.94% Unkown
HY-114293S Acetyl coenzyme A-13C2 lithium Inhibitor 97.40% Unkown
HY-101159 Mal-amido-PEG8-C2-acid 99.04% Unkown
HY-130531 NH-bis(C2-PEG2-NH-Boc) 99.93% Unkown
HY-134512A Aminooxy-PEG3-C2-thiol hydrochloride 99.73% Unkown
HY-134682 Fmoc-NH-PEG5-C2-NH2 98.06% Unkown
HY-140013 Fmoc-NH-PEG1-C2-acid 99.83% Unkown
HY-140480 Acid-PEG2-C2-Boc 98.0% Unkown
HY-W008567 N-Deschlorobenzoyl indomethacin 95.0% Unkown
HY-B0228S10 (R)-3-Hydroxybutanoic acid-13C2 sodium 98.0% Unkown
HY-156305 Coumarin-C2-exo-BCN 95.70% Unkown
HY-N0394S4 L-Cystine-3,3'-13C2 99.0% Unkown
HY-Y0966S6 Glycine-13C2,15N 99.92% Unkown
HY-W021448S1 Glycocyamine-15N,13C2 97.40% Unkown
HY-108307 Micronomicin sulfate Inhibitor 99.96% Unkown
HY-128846A Pomalidomide-C2-NH2 hydrochloride 99.46% Unkown
HY-130396 DBCO-PEG4-C2-acid 99.22% Unkown
HY-138380 Mal-PEG4-C2-NH2 TFA 98.60% Unkown
HY-140222 Amino-PEG2-C2-hydrazide-Boc ≥97.0% Unkown
HY-140481 Acid-PEG5-C2-Boc 99.57% Unkown
HY-B0389S15 D-Glucose-13C2-4 99.98% Unkown
HY-P5881 PKCα (C2-4) inhibitor peptide Inhibitor 99.50% Unkown
HY-W008807S Phosphoenolpyruvic acid potassium-13C2 97.00% Unkown
HY-W157376 PAMAM Dendrimer G0.0 amine (20% in methanol) Inhibitor / Unkown
HY-W016510 Benzenesulfonate sodium 99.61% Unkown
HY-112706 PF-06747711 Antagonist 99.83% Unkown
HY-130436 Acid-C2-PEG4-C2-NHS ester 98.0% Unkown
HY-135085 Thiol-C2-PEG2-OH 97.83% Unkown
HY-138406 Boc-NH-PEG8-C2-Br 99.81% Unkown
HY-141117 Boc-NH-PEG2-C2-NHS ester ≥98.0% Unkown
HY-168708 AH2-14c 98.01% Unkown
HY-B0863S3 Glyphosate-13C2,15N Inducer 99.9% Unkown
HY-N3431 Kaempferol-7-O-rhamnoside 99.18% Unkown
HY-W008137 5-Bromo-2-fluoropyrimidine 99.70% Unkown
HY-W040795 N2-Acetylguanine 99.92% Unkown
HY-40347 Boc-Azetidine-C2-NH2 ≥97.0% Unkown
HY-N0830S10 Palmitic acid-13C2 Activator 99.54% Unkown
HY-W017387S1 Sodium α-ketoisocaproic acid-13C2 99.95% Unkown
HY-128591 DIPQUO Activator 98.70% Unkown
HY-130521 Pomalidomide-amido-PEG3-C2-NH2 99.11% Unkown
HY-137531 Pomalidomide-PEG1-C2-COOH 99.76% Unkown
HY-102052 DCEBIO Activator 99.25% Unkown
HY-130101 Ald-Ph-amido-PEG4-C2-NHS ester 98.12% Unkown
HY-130414 Mal-amido-PEG4-acid 99.76% Unkown
HY-130713 Thalidomide-C2-amido-C2-COOH 98.45% Unkown
HY-137822 p-Nitrophenyl α-D-mannopyranoside 98.88% Unkown
HY-140001 Amino-PEG3-C2-sulfonic acid 99.47% Unkown
HY-140819 Bromo-PEG1-C2-azide 99.45% Unkown
HY-141116 Boc-N-PEG1-C2-NHS ester 98.0% Unkown
HY-N0229S9 L-Alanine-13C2 99.97% Unkown
HY-P2741 Maltose phosphorylase / Unkown
HY-D1546 Biotin-C2-maleimide 99.48% Unkown
HY-W006057AS17 Sodium 3-Methyl-2-oxobutanoic acid-13C2 99.90% Unkown
HY-W014780 α-Amylcinnamaldehyde 99.74% Unkown
HY-130683 Lenalidomide-propargyl-C2-NH2 hydrochloride 98.01% Unkown
HY-13836 ELQ-300 Inhibitor 98.0% Unkown
HY-B1659S4 Glycerol-13C2 99% Unkown
HY-122710A Thalidomide-O-amido-PEG4-C2-NH2 hydrochloride Inducer 95.0% Unkown
HY-128832 Nutlin-C1-amido-PEG4-C2-N3 95.01% Unkown
HY-115384 Amino-PEG5-C2-acid 97.0% Unkown
HY-124648 SMN-C2 98.85% Unkown
HY-128716B Pomalidomide-PEG3-C2-NH2 hydrochloride 96.64% Unkown
HY-130108 N3-PEG4-C2-Pfp ester ≥97.0% Unkown
HY-141240 Hydroxy-PEG2-C2-methyl ester 98.48% Unkown
HY-141386 Bromoacetamido-PEG2-C2-NHS ester 95.0% Unkown
HY-143657 Myoferlin inhibitor 1 Inhibitor 99.88% Unkown
HY-42151 Mal-amido-PEG2-C2-acid 99.80% Unkown
HY-W010098S1 Terephthalic acid-13C2 99.60% Unkown
HY-66005S4 Acetaminophen-13C2,15N 98.30% Unkown
HY-W015410S Disodium succinate-13C2 99.3% Unkown
HY-112608 CHMFL-PI3KD-317 Inhibitor 98.04% Unkown
HY-122694A Thalidomide-O-amido-PEG-C2-NH2 hydrochloride Inducer 98.10% Unkown
HY-131880 Thalidomide-O-C2-acid Inducer 95.04% Unkown
HY-100246 CI-1044 Inhibitor 98.02% Unkown
HY-103611 Thalidomide-O-amido-PEG3-C2-NH2 TFA Inducer 99.55% Unkown
HY-115450 ONO-0300302 Antagonist 98.02% Unkown
HY-130091 NHPI-PEG4-C2-NHS ester 98.88% Unkown
HY-130488 Hydroxy-PEG2-C2-PFP ester ≥97.0% Unkown
HY-130654 (S,R,S)-AHPC-C2-PEG4-N3 97.63% Unkown
HY-133597 4-Chlorocatechol 99.37% Unkown
HY-140426 Boc-Aminooxy-PEG2-C2-amine 99.70% Unkown
HY-141122 Boc-PEG4-C2-NHS ester / Unkown
HY-141242 Hydroxy-PEG4-C2-methyl ester ≥97.0% Unkown
HY-141388 Bromoacetamido-PEG3-C2-Boc / Unkown
HY-148080 Indole-C2-amide-C2-NH2 97.12% Unkown
HY-148896 (S,R,S)-AHPC-C2-PEG3-BCN 98.44% Unkown
HY-169150 JQ-1 carboxylic acid-PEG3-C2-NH2 99.39% Unkown
HY-169387 YT 6-2-PEG3-C2-NH2 Control 99.50% Unkown
HY-B0216S2 Ethynyl Estradiol-13C2 Agonist 98.64% Unkown
HY-B0318S Metronidazole-13C2,15N2 99.30% Unkown
HY-B2176S7 ATP-13C2 dilithium 96.0% Unkown
HY-N0455AS5 L-Arginine-1,2-13C2 hydrochloride Activator 98.9% Unkown
HY-N0666S6 L-Aspartic acid-1,4-13C2 Agonist 99.66% Unkown
HY-N3205 Neochamaejasmin B 98.53% Unkown
HY-133358 Cbz-NH-PEG12-C2-acid 95.66% Unkown
HY-150006 Pomalidomide-C2-acid 99.78% Unkown
HY-185060 N-Acetyllactosamine-C2-NH2 / Unkown
HY-N0091S3 Hypoxanthine-13C2,15N 91.7% Unkown
HY-W414731 N-(3-Methylphenyl)anthranilic acid 99.82% Unkown
HY-W590664 C2 Dihydroceramide 99.9% Unkown
HY-136160 Thalidomide 4'-oxyacetamide-alkyl-C2-amine hydrochloride 99.30% Unkown
HY-13966S2 2-Deoxy-D-glucose-13C 99.48% Unkown
HY-B0389S14 D-Glucose-13C2 98.0% Unkown
HY-136163 (S,R,S)-AHPC-C2-NH2 dihydrochloride 98.63% Unkown
HY-113294S2 3-Hydroxykynurenine-13C2,15N hydrochloride Inducer 98.74% Unkown
HY-125172 PolyQ aggregation inhibitor C2-8 Inhibitor 99.9% Unkown
HY-126502 Mal-C2-NHS ester 99.30% Unkown
HY-126508 Mal-amido-PEG5-C2-​NHS ester ≥98.0% Unkown
HY-126509 Mal-amido-PEG10-C2-​NHS ester 98.0% Unkown
HY-126881 Fmoc-PEG2-C2-NHS ester 98.89% Unkown
HY-130489 Bromo-PEG5-C2-acid 98.0% Unkown
HY-130520 Bromoacetamido-PEG4-C2-Boc 99.84% Unkown
HY-131866 (S,R,S)-CO-C2-acid 98.0% Unkown
HY-135868 Mito-apocynin (C2) Inhibitor 98.41% Unkown
HY-136162 Thalidomide-4-O-C2-NH2 hydrochloride Inducer 99.37% Unkown
HY-138381 Br-PEG6-C2-NHBoc 98.0% Unkown
HY-139848 WS-898 Inhibitor 98.51% Unkown
HY-140256 NH-bis(PEG2-C2-Boc) ≥98.0% Unkown
HY-140261 NH-bis(PEG4-C2-NH-Boc) ≥97.0% Unkown
HY-140383 Ms-PEG2-C2-Boc ≥97.0% Unkown
HY-140487 Cbz-NH-PEG2-C2-acid 97.0% Unkown
HY-140488 Cbz-NH-PEG3-C2-acid 99.82% Unkown
HY-140776 Azido-PEG2-C2-Boc 95.0% Unkown
HY-141380 Bromoacetamido-PEG2-C2-acid 99.82% Unkown
HY-160897 Methoxy-PEG2000-C3-amide-C2-Mal 99.69% Unkown
HY-171342 Mal-C2-amide-C10-tri-GalNAc Ligand 99.54% Unkown
HY-171814 Mal-PEG2-amide-C2-amide-Phenyl(β-D-glucuronide)-NMT-IN-7 Inhibitor 95.42% Unkown
HY-176518 ssPalmE-P4-C2 98.81% Unkown
HY-B0220S3 Erythromycin-13C2 Inhibitor ≥95.0% Unkown
HY-N0390S10 L-Glutamine-1,2-13C2 98.0% Unkown
HY-N0473S6 L-Tyrosine-3,5-13C2 99.98% Unkown
HY-N6980 Licorice glycoside C2 99.07% Unkown
HY-W013495S Porphobilinogen-13C2 97.39% Unkown
HY-W127841 Citric acid-2,4-13C2 98.00% Unkown
HY-W777012 Acridinium C2 NHS ester 92.11% Unkown
HY-W998278A Desamino lenalidomide-acetylene-C2-NH2 TFA / Unkown
HY-Y0338S1 Ethylene glycol-13C2 99.9% Unkown
HY-132212 LH1307 Inhibitor 96.9% Unkown
HY-155705 BMP agonist 1 / Unkown
HY-W013636S3 2-Ketoglutaric acid-13C Inhibitor 97.94% Unkown
HY-W074889S3 N-Myristoylglycine-13C2 99.93% Unkown
HY-W336455 Cbz-PEG2-C2-NH2 99.08% Unkown
HY-W584710 Desamino lenalidomide-C2-COOH 98.29% Unkown
HY-Y0674S Dicyandiamide-13C2,15N2 99.90% Unkown
HY-107440 Thalidomide-O-amido-PEG3-C2-NH2 Inducer / Unkown
HY-112600A Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 TFA Inducer 99.28% Unkown
HY-112617A Thalidomide-O-amido-PEG2-C2-NH2 TFA Inducer 99.72% Unkown
HY-112617B Thalidomide-O-amido-PEG2-C2-NH2 hydrochloride Inducer / Unkown
HY-128716A Pomalidomide-PEG3-C2-NH2 TFA 99.0% Unkown
HY-129703A Thalidomide-PEG2-C2-NH2 TFA Inducer 99.13% Unkown
HY-130682 Lenalidomide-propargyl-C2-amido-Ph-NH2 hydrochloride / Unkown
HY-130853 Thalidomide-NH-PEG2-C2-NH-Boc Inducer 98.37% Unkown
HY-107440A Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride Inducer 98.29% Unkown
HY-112599 Pomalidomide-PEG4-C2-NH2 95.11% Unkown
HY-103154 SB228357 Antagonist 99.43% Unkown
HY-108440 Shz-1 99.88% Unkown
HY-109506S9 DPPC-13C2 95.0% Unkown
HY-113071 Mevalonic acid ≥99.0% Unkown
HY-113365S2 Cholestenone-13C2 99.77% Unkown
HY-120773 Fmoc-PEG3-C2-NHS ester ≥95.0% Unkown
HY-121982 Cyclo(L-Phe-L-Val) Inhibitor 99.88% Unkown
HY-126381 Boc-N-PEG5-C2-NHS ester 96.91% Unkown
HY-126507 Mal-amido-PEG1-C2-​NHS ester 99.69% Unkown
HY-128716 Pomalidomide-PEG3-C2-NH2 / Unkown
HY-128846 Pomalidomide-C2-NH2 / Unkown
HY-128848 Pomalidomide-C2-amido-(C1-O-C5-O-C1)2-COOH 93.92% Unkown
HY-130095 NHPI-PEG2-C2-NHS ester 98.23% Unkown
HY-130097 Ald-Ph-amido-PEG4-C2-acid 99.09% Unkown
HY-130104 Ald-Ph-amido-PEG2-C2-NHS ester 98.51% Unkown
HY-130470 Chloroacetamido-PEG4-C2-Boc ≥97.0% Unkown
HY-131295 PD0325901-O-C2-dioxolane Inhibitor 98.62% Unkown
HY-133070 Tos-PEG5-C2-Boc ≥97.0% Unkown
HY-133071 Tos-PEG6-C2-Boc / Unkown
HY-133410A Mal-C2-cyclohexylcarboxyl-hydrazide hydrochloride 98.00% Unkown
HY-134512 Aminooxy-PEG3-C2-thiol / Unkown
HY-136395 Cartap Inducer / Unkown
HY-13677S1 6-Mercaptopurine-13C2,15N 96.0% Unkown
HY-138358 Azido-PEG23-C2-azide 95.0% Unkown
HY-138451 Amino-PEG7-C2-SH hydrochloride 98.0% Unkown
HY-138857A Thalidomide-NH-amido-PEG4-C2-NH2 hydrochloride 98.01% Unkown
HY-140002 Amino-PEG1-C2-acid 98.0% Unkown
HY-140101 Azido-C2-SS-PEG2-C2-acid 98.23% Unkown
HY-140465 Fmoc-NMe-PEG4-C2-acid 97.0% Unkown
HY-140479 Acid-PEG1-C2-Boc / Unkown
HY-140482 Acid-PEG6-C2-Boc / Unkown
HY-140530 Mal-N-bis(PEG4-C2-acid) 98.0% Unkown
HY-140541 Tri-(PEG1-C2-acid) ≥95.0% Unkown
HY-140543 N-DBCO-N-bis(PEG2-C2-acid) 96.65% Unkown
HY-140779 Azido-PEG6-C2-Boc 99.77% Unkown
HY-140964 Mal-PEG2-C2-Boc / Unkown
HY-141243 Hydroxy-PEG5-C2-methyl ester 98.97% Unkown
HY-141658 Pomalidomide-PEG6-C2-COOH 98.95% Unkown
HY-141798 OICR-9429-N-C2-NH2 Ligand / Unkown
HY-144427S Vitamin E-13C2,d6 Inhibitor 98.0% Unkown
HY-145245 TLR4-IN-C34-C2-amide-C6-OH Inhibitor 99.62% Unkown
HY-14608S10 L-Glutamic acid-13C2 99.7% Unkown
HY-148346 STING agonist-20-Ala-amide-PEG2-C2-NH2 Agonist / Unkown
HY-148346A STING agonist-20-Ala-amide-PEG2-C2-NH2 TFA Agonist 98.30% Unkown
HY-148484 Pomalidomide-5'-PEG5-C2-COOH 98.08% Unkown
HY-148662 Pomalidomide-PEG5-C2-NH2 hydrochloride / Unkown
HY-149559 Thalidomide-5-O-C2-NH2 hydrochloride Inducer 99.55% Unkown
HY-150631S Glutathione-glycine-13C2,15N trifluoroacetate 99.86% Unkown
HY-156304 Coumarin-C2-TCO 98.10% Unkown
HY-158470 Disialylated Core 2 O-glycan (C2S(3,3)2), 2-AB labelled / Unkown
HY-160109A Ac5GalNTGc epimer Inhibitor 98.39% Unkown
HY-164785 TCO-PEG5-C2-Mal 95.0% Unkown
HY-172144 JB300 Degrader 98% Unkown
HY-176947 Demethyl-sapanisertib-C2-amide-PEG7-C2-N3 99.78% Unkown
HY-A0132S10 N-Acetyl-D-glucosamine-13C2,15N / Unkown
HY-B0151S1 Pregnenolone-13C2,d2 99.2% Unkown
HY-B0166S3 L-Ascorbic acid-13C-2 95.0% Unkown
HY-B0579S3 Cyclosporin A-13C2,d4 Inhibitor 95.21% Unkown
HY-I0960S Uracil-13C2,15N2 ≥97.0% Unkown
HY-N0229S15 L-Alanine-13C2,15N 99.98% Unkown
HY-N0545S Taurocholic acid-13C2,15N sodium Agonist / Unkown
HY-N3697 Demethoxydeacetoxypseudolaric acid B 99.76% Unkown
HY-RS09537 NR2C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10511 PIK3C2A Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W015883S1 Fumaric acid-13C2 99.9% Unkown
HY-W015883S2 Fumaric acid-13C2,d2 98.00% Unkown
HY-W017049S Sodium trifluoroacetate-13C2 / Unkown
HY-W141374 CB096 98.72% Unkown
HY-W580022 Pomalidomide-5'-PEG8-C2-COOH 98.21% Unkown
HY-W654105 C18-Ceramide-13C2,d2 95.40% Unkown
HY-W654241 Isopentenyl pyrophosphate-13C2 ammonium 99.90% Unkown
HY-W750263 Pyruvic acid-13C2 95% Unkown
HY-W777360 Harman-13C2,15N Inhibitor 99.66% Unkown
HY-W778202 2-Oxoacetic acid hydrate-13C2 99.9% Unkown
HY-Y0781S3 Pyruvic acid-1-13C-2 sodium 99% Unkown
HY-Y0966S11 Glycine-13C2,15N,d2 98.71% Unkown
HY-103708 Nezukone 98.81% Unkown
HY-158080 2-Keto-L-gulonic acid Inhibitor 95.0% Unkown
HY-159193S DHATS(Leu-13C6,15N)PVTIPSAVST(Gly-13C2,15N)HTTPLPVTDT TFA 97.61% Unkown
HY-16973S Fluralaner-13C2,15N,d3 Inhibitor 98.35% Unkown
HY-176422 (S,R,S)-AHPC-Amide-PEG2-C2-NH2 97.16% Unkown
HY-186055 Antimalarial agent 58 Inhibitor / Unkown
HY-47373 Folate-PEG3-C2-acid 97.56% Unkown
HY-B0124S1 Zonisamide-13C2,15N 99.53% Unkown
HY-N0420S3 Succinic acid-13C2-1 99.0% Unkown
HY-N0437S3 Progesterone-13C2 Agonist 99.7% Unkown
HY-N7521 Procyanidin C2 / Unkown
HY-W025074 BML-278 Activator 98.49% Unkown
HY-W069545 (S)-1-Tetralol 99.75% Unkown
HY-W128417S 4-(Dimethylamino)phenacyl bromide-13C2,d6 98.14% Unkown
HY-W157319 Cyano-C2-PEG3-cyano ≥95.0% Unkown
HY-W998278 Desamino lenalidomide-acetylene-C2-NH2 / Unkown
HY-W998284 Thalidomide-O-C2-alkyne 99.67% Unkown
HY-112600 Thalidomide-O-amido-PEG1-(C1-PEG)2-C2-NH2 Inducer / Unkown
HY-112617 Thalidomide-O-amido-PEG2-C2-NH2 Inducer / Unkown
HY-122694 Thalidomide-O-amido-PEG-C2-NH2 Inducer / Unkown
HY-128353 ROR agonist-1 Antagonist / Unkown
HY-129703 Thalidomide-PEG2-C2-NH2 Inducer / Unkown
HY-131308 Thalidomide-NH-C2-PEG3-OH Inducer / Unkown
HY-79369S1 Succinic anhydride-13C2 / Unkown
HY-B0712S1 Ceftriaxone-13C2,d3 triethylammonium salt Inhibitor / Unkown
HY-B0782S1 Acetazolamide-13C2,d3 / Unkown
HY-B1449S3 Uridine-13C-2 99.9% Unkown
HY-B1892S1 Cefazolin-13C2,15N Inhibitor / Unkown
HY-N0210S1 D-Galactose-13C-2 99.96% Unkown
HY-W015913S4 Pyruvic acid-13C2-1 sodium 99.0% Unkown
HY-Y1250S6 Fmoc-Gly-OH-13C2,15N 99.6% Unkown
HY-122710 Thalidomide-O-amido-PEG4-C2-NH2 / Unkown
HY-125883 Pomalidomide-amido-C4-amido-PEG2-C2-NH-Boc / Unkown
HY-100441S1 Treprostinil-13C2,d1 Inhibitor / Unkown
HY-101047S1 D-erythro-Sphingosine-13C2,d2 / Unkown
HY-101108S1 Tazarotenic acid-13C2,d2 / Unkown
HY-101180A (E/Z)-C2 Ceramide / Unkown
HY-103155 SB-221284 Antagonist / Unkown
HY-107855S4 DL-Mevalonolactone-13C2 / Unkown
HY-108379 Boc-C2-Urea-bis(Boc)-C4-Urea-4-phenylacetic acid 96.87% Unkown
HY-110189S Pregnenolone monosulfate sodium-13C2,d2 / Unkown
HY-111555 AmPEG6C2-Aur0131 Inhibitor / Unkown
HY-112599A Pomalidomide-PEG4-C2-NH2 TFA / Unkown
HY-112880 c-(2'FdAMP-2'FdIMP) / Unkown
HY-113071C (S)-Mevalonic acid / Unkown
HY-113150S2 Hexanoylglycine-13C2,15N / Unkown
HY-113263S1 17α-Hydroxypregnenolone-13C2,d2 / Unkown
HY-113295S Salicyluric acid-13C2,15N / Unkown
HY-115945 Complex III-IN-1 Inhibitor / Unkown
HY-116700 Hinnuliquinone Inhibitor / Unkown
HY-116877 C2 Ceramide (d14:1/2:0) / Unkown
HY-118411S1 5-Ethynyl-2'-deoxyuridine-13C2 / Unkown
HY-118574 UBP141 Antagonist / Unkown
HY-121507 Hydroxy-PEG2-C2-sulfonic acid / Unkown
HY-121656 AKR1C2/3-IN-2 Inhibitor / Unkown
HY-123439 FTY720-C2 Inhibitor 99.64% Unkown
HY-123659 KR-33028 Inhibitor / Unkown
HY-125026 MyomiRs-IN-1 / Unkown
HY-12516S2 Desogestrel-13C2,d2-1 / Unkown
HY-125887 Boc-NH-PEG2-C2-amido-C4-acid / Unkown
HY-126313 BnOH-NH-bis-(C2-S)-propane-O-isoprene ester / Unkown
HY-12650S Mirogabalin-13C2,d1 (Mixture of Diastereomers) / Unkown
HY-126510 MC-PEG2-C2-​NHS ester / Unkown
HY-126514 Propargyl-O-C1-amido-PEG2-C2-NHS ester / Unkown
HY-126515 Propargyl-O-C1-amido-PEG4-C2-NHS ester 95.0% Unkown
HY-126527 N3-PEG2-C2-PFP ester / Unkown
HY-126529 N3-PEG3-C2-PFP ester / Unkown
HY-126673 Mal-C2-Gly3-EDA / Unkown
HY-126677 Boc-NH-PEG3-C2-triazole-DBCO-PEG4-VC-PAB-DMEA / Unkown
HY-128417S2 D-Glucose-1,6-13C2 / Unkown
HY-128741S2 D-Allose-13C-2 / Unkown
HY-128753S3 D-Lyxose-13C-2 / Unkown
HY-128793S trans-Stilbene-13C2 / Unkown
HY-129772 Phthalimide-PEG3-C2-OTs / Unkown
HY-130090 NHPI-PEG4-C2-Pfp ester ≥97.0% Unkown
HY-130092 NHPI-PEG3-C2-Pfp ester / Unkown
HY-130093 NHPI-PEG3-C2-NHS ester / Unkown
HY-130094 NHPI-PEG2-C2-Pfp ester / Unkown
HY-130096 Ald-Ph-amido-C2-nitrate / Unkown
HY-130102 Ald-Ph-amido-PEG3-C2-Pfp ester / Unkown
HY-130103 Ald-Ph-amido-PEG2-C2-Pfp ester / Unkown
HY-130105 Ald-Ph-amido-PEG1-C2-Pfp ester / Unkown
HY-130106 Ald-Ph-amido-PEG1-C2-NHS ester / Unkown
HY-130154 Ald-Ph-amido-PEG2-C2-acid / Unkown
HY-130164 Bromo-PEG3-C2-phosphonic acid / Unkown
HY-130174 Ald-Ph-amido-PEG3-C2-NH2 / Unkown
HY-130192 Cbz-NH-PEG8-C2-acid / Unkown
HY-130202 Ald-Ph-amido-PEG2-C2-Boc 97.0% Unkown
HY-130443 Cbz-NH-PEG6-C2-acid / Unkown
HY-130467 DNP-NH-PEG2-C2-acid / Unkown
HY-130491 DNP-NH-PEG4-C2-Boc / Unkown
HY-130667 Ald-Ph-amido-C2-PEG3-azide 98.92% Unkown
HY-130669 Ald-Ph-amido-C2-PEG3-NH-Boc / Unkown
HY-130690 Propargyl-PEG1-SS-PEG1-C2-Boc 98.0% Unkown
HY-130712 NH2-C2-amido-C2-Boc / Unkown
HY-130758 Ald-PEG1-C2-Boc / Unkown
HY-130931 Propargyl-NH-PEG3-C2-NHS ester / Unkown
HY-131787A 2-Amino-ATP tetrasodium / Unkown
HY-131992 N-Acetylpsychosine / Unkown
HY-132031 Mal-Val-Ala-PAB(C2-glucuronic acid)-DMEA-PNU-159682 / Unkown
HY-132644S1 3-Demethylthiocolchicine-13C2,d6 / Unkown
HY-132973 MC-Val-Cit-PAB-NH-C2-NH-Boc 95.0% Unkown
HY-133069 Tos-PEG2-C2-Boc / Unkown
HY-133410 Mal-C2-cyclohexylcarboxyl-hydrazide TFA / Unkown
HY-133509 DBCO-C2-SulfoNHS ester / Unkown
HY-133546 Ald-Ph-amido-PEG11-C2-NH2 / Unkown
HY-133583 Propargyl-O-C1-amido-PEG3-C2-NHS ester / Unkown
HY-13407S Gossypol-13C2 / Unkown
HY-13417S AICAR-13C2,15N / Unkown
HY-13458S1 Droxidopa-13C2,15N hydrochloride / Unkown
HY-135959 DBCO-NH-PEG7-C2-NHS ester / Unkown
HY-136162A Thalidomide-4-O-C2-NH2 Inducer / Unkown
HY-136163A (S,R,S)-AHPC-C2-NH2 / Unkown
HY-13623CS (1R,3S,4R)-ent-Entecavir-13C2,15N / Unkown
HY-13623S1 Entecavir-13C2,15N Inhibitor / Unkown
HY-138083 Parvodicin C2 Inhibitor / Unkown
HY-138316 THP-PEG10-C2-Boc / Unkown
HY-138349 THP-PEG6-C2-Boc / Unkown
HY-138362 Br-PEG6-C2-acid / Unkown
HY-138370 Boc-NH-PEG4-C2-Boc / Unkown
HY-138375 Mal-PEG5-C2-NH2 hydrochloride / Unkown
HY-138384 Br-PEG9-C2-NHBoc / Unkown
HY-138390 NH2-PEG10-C2-dimethylamino / Unkown
HY-138397 Boc-NH-PEG15-C2-acid / Unkown
HY-138399 Boc-NH-PEG22-C2-NH2 / Unkown
HY-138410 Boc-NH-PEG11-C2-acid / Unkown
HY-138432 Boc-NH-PEG26-C2-NH2 / Unkown
HY-138464 Br-Boc-C2-azido / Unkown
HY-138474 Boc-PEG1-PPG2-C2-azido / Unkown
HY-138485 Boc-PEG1-PPG2-C2-NH2 / Unkown
HY-138535 Azide-C2-Azide / Unkown
HY-138849 Thalidomide-NH-amido-C2-NH2 Inducer / Unkown
HY-138849A Thalidomide-NH-amido-C2-NH2 hydrochloride Inducer / Unkown
HY-138854 Thalidomide-NH-amido-PEG1-C2-NH2 Inducer / Unkown
HY-138854A Thalidomide-NH-amido-PEG1-C2-NH2 hydrochloride Inducer / Unkown
HY-138855 Thalidomide-NH-amido-PEG2-C2-NH2 Inducer / Unkown
HY-138855A Thalidomide-NH-amido-PEG2-C2-NH2 hydrochloride Inducer / Unkown
HY-138856 Thalidomide-NH-amido-PEG3-C2-NH2 Inducer / Unkown
HY-138856A Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride / Unkown
HY-138857 Thalidomide-NH-amido-PEG4-C2-NH2 / Unkown
HY-138965A Pomalidomide-5-C2-NH2 hydrochloride / Unkown
HY-139084 XL388-C2-NH2 / Unkown
HY-139085A XL388-C2-amide-PEG9-NH2 hydrochloride 95.0% Unkown
HY-139085B XL388-C2-amide-PEG9-NH2 TFA 95.97% Unkown
HY-140011 Acid-C2-PEG3-NHS ester / Unkown
HY-140085 N-(PEG2-C2-acid)-N-bis(PEG2-propargyl) / Unkown
HY-140164 Azido-PEG2-C2-sulfonic acid / Unkown
HY-140221 Azido-PEG1-C2-methylamine / Unkown
HY-140260 NH-bis(PEG3-C2-NH-Boc) / Unkown
HY-140287 DBCO-C2-PEG4-amine / Unkown
HY-140294 DBCO-C2-PEG4-NH-Boc / Unkown
HY-140349 AZD-CO-C2-Ph-amido-Ph-azide / Unkown
HY-140375 Tos-PEG3-C2-methyl ester / Unkown
HY-140401 Aminooxy-PEG3-C2-Boc / Unkown
HY-140402 Aminooxy-PEG4-C2-Boc / Unkown
HY-140406 Aminooxy-PEG3-C2-NH-Boc / Unkown
HY-140425 Boc-Aminooxy-PEG1-C2-NH2 / Unkown
HY-140427 Boc-Aminooxy-PEG3-C2-NH2 / Unkown
HY-140489 Cbz-NH-PEG5-C2-acid / Unkown
HY-140508 m-PEG12-NH-C2-acid / Unkown
HY-140514 NH-bis(PEG2-C2-acid) / Unkown
HY-140550 NH-bis(C2-PEG1-azide) / Unkown
HY-140554 N-Boc-N-bis(C2-PEG1-azide) / Unkown
HY-140576 N-Mal-N-bis(PEG2-C2-Boc) / Unkown
HY-140595 m-PEG3-S-PEG1-C2-Boc / Unkown
HY-140632 Ald-Ph-amido-C2-PEG2-amine / Unkown
HY-140633 Ald-C2-PEG4-azide / Unkown
HY-140745 Benzyloxy carbonyl-PEG3-C2-acid / Unkown
HY-140750 Benzyloxy carbonyl-PEG3-C2-Boc / Unkown
HY-140834 Boc-N-Amido-PEG2-C2-azide / Unkown
HY-141199 Bromoacetamido-C2-PEG2-NH-Boc / Unkown
HY-141239 Hydroxy-PEG1-C2-methyl ester / Unkown
HY-141241 Hydroxy-PEG3-C2-methyl ester / Unkown
HY-141245 Hydroxy-PEG4-C2-nitrile / Unkown
HY-141250 Hydroxy-Amino-bis(PEG1-C2-Boc) / Unkown
HY-141323 C2-Bis-phosphoramidic acid diethyl ester / Unkown
HY-141349 S-Acetyl-PEG3-C2-acid / Unkown
HY-141381 Bromoacetamido-PEG3-C2-acid / Unkown
HY-141662 2',3'-cGAMP-C2-PPA Agonist / Unkown
HY-141878 di-Ellipticine-RIBOTAC / Unkown
HY-141878A di-Ellipticine-RIBOTAC TFA / Unkown
HY-143683S Theophylline-13C2,d6 / Unkown
HY-143943S Felodipine 3,5-dimethyl ester-13C2,d6 / Unkown
HY-144128 hGGPPS-IN-1 / Unkown
HY-144129 hGGPPS-IN-2 / Unkown
HY-144130 hGGPPS-IN-3 / Unkown
HY-144150S Pelubiprofen impurity 2-13C2,d6 / Unkown
HY-144153S S-(1,2-Dichlorovinyl)glutathione-13C2,15N / Unkown
HY-145247 Biotin-PEG7-C2-S-Vidarabine Inhibitor / Unkown
HY-145248 Biotin-PEG7-C2-NH-Vidarabine-S-CH3 Inhibitor / Unkown
HY-145253 Tri(TLR4-IN-C34-C2-amide-PEG1)-amide-C3-COOH Inhibitor / Unkown
HY-145255 Tri(TLR4-IN-C34-C2-amide-C3-amide-PEG1)-amide-C3-COOH Inhibitor / Unkown
HY-146194 NHEJ inhibitor-1 Activator / Unkown
HY-146196 Anticandidal agent-1 Inhibitor / Unkown
HY-146573 AKR1C3-IN-6 / Unkown
HY-146994S2 L-Idose-13C-2 / Unkown
HY-14749AS1 Pyronaridine-13C2,d4 tetraphosphate / Unkown
HY-147716 CDK8-IN-6 Inhibitor / Unkown
HY-147717 CDK8-IN-7 Inhibitor / Unkown
HY-147835 Antibacterial agent 109 Inhibitor / Unkown
HY-148171 L-2'-Fd4C Inhibitor / Unkown
HY-148472A C2-Amide-C4-NH2 / Unkown
HY-149255 PTP1B/AKR1B1-IN-2 Inhibitor / Unkown
HY-150623 SARS-CoV-2 nsp13-IN-2 Inhibitor / Unkown
HY-150658S1 DMT-2′O-TBDMS-rA(ac) phosphoramidite-13C2 / Unkown
HY-150915S Uracil 4,5-13c2 / Unkown
HY-152297 (1S)-1,4-Anhydro-1-C-(2,4-difluorophenyl)-D-ribitol / Unkown
HY-152305 (1S)-1,4-Anhydro-1-C-(2,4-difluoro-5-methylphenyl)-D-ribitol / Unkown
HY-152463 4′-C-2-Propen-1-yluridine / Unkown
HY-153042 Thalidomide-NH-C2-azaspiro[3.5]nonane hydrochloride / Unkown
HY-153371 50-C2-C9-4tail / Unkown
HY-153538 AP-C2 Inhibitor 99.42% Unkown
HY-15388S1 Tazarotene-13C2,d2 / Unkown
HY-156207 C2 Adamantanyl globotriaosylceramide (d18:1/2:0) Inhibitor / Unkown
HY-156208 C2 Adamantanyl galactosylceramide (d18:1/2:0) / Unkown
HY-156882 Biotin-PEG3-amide-C2-CO-Halofuginone / Unkown
HY-157182 DNP-PEG2-NHCO-C2-DBCO / Unkown
HY-157386S 8-(o-Fluoro-benzyl)theophylline methylsulfonyl-13C2 / Unkown
HY-157588 (S)-Thalidomide-Piperazine-CH2-Pyrrolidine-C2-OH Inducer / Unkown
HY-157749 Thalidomide-piperazine-(S)-CH2-pyrrolidine-C2-O-CH2-COO-C(CH3)3 Inducer / Unkown
HY-157758 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-CH2-COO-C(CH3)3 Inducer / Unkown
HY-157759 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-O-C2-OH Inducer / Unkown
HY-157760 (S)-Thalidomide-piperazine-pyrimidine-piperazine-C2-OH Inducer / Unkown
HY-160449 p53 Activator 10 Activator / Unkown
HY-160514 LXQ46 Inhibitor 99.14% Unkown
HY-161183 (S)-Thalidomide-O-(1S,3r)-C4H4-N(Me)-Pip-C2-O-C-boc Inducer / Unkown
HY-161184 Deoxy-thalidomide-piperidine-C-piperazine-C2-OH Inducer / Unkown
HY-161186 Thalidomide-piperidine-C-azetidine-C2-O-C-boc Inducer / Unkown
HY-161188 Thalidomide-O-C4H4-N(Me)-piperidine-C2-OH Inducer / Unkown
HY-161189 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C-boc Inducer / Unkown
HY-161190 Thalidomide-piperidine-C-2,6-diazaspiro[3.3]heptane-C2-OH Inducer / Unkown
HY-161191 Thalidomide-azetidine-piperazine-C2-O-C2-OH Inducer / Unkown
HY-161197 Thalidomide-2,6-diazaspiro[3.4]octane-C-piperidine-C2-O-C2-OH Inducer / Unkown
HY-161199 Thalidomide-azetidine-pyrrolidine-C-piperidine-C2-OH Inducer / Unkown
HY-161200 Thalidomide-piperazine-C-azetidine-C2-OH Inducer / Unkown
HY-161202 Thalidomide-piperidine-O-piperidine-C2-OH Inducer / Unkown
HY-161203 Thalidomide-azetidine-piperazine-C2-O-C-boc Inducer / Unkown
HY-161250 Pomalidomide-NH-PEG6-amide-C2-CPI-1612 Degrader / Unkown
HY-161393 RB-CO-PEG5-C2-CO-VH032 / Unkown
HY-161394 SPRT / Unkown
HY-161839 AKR1C2/3-IN-1 / Unkown
HY-161910 SH-E4A-66 Inhibitor / Unkown
HY-162046 Anticancer agent 178 Inducer / Unkown
HY-162081 BTK-IN-32 Inhibitor / Unkown
HY-16271S Kevetrin-13C2,15N3 hydrochloride p53 Activator / Unkown
HY-163078 C2-Gal-Dox / Unkown
HY-163224 (S)-PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / Unkown
HY-163228 PROTAC PTK6 ligand-O-C2-O-piperidine-Boc / Unkown
HY-163609 PROTAC AKR1C3 degrader-1 Degrader / Unkown
HY-163788 C5-CONH-C2-N-CH3 / Unkown
HY-163903 OH-C2-PEG3-NHCO-C3-COOH / Unkown
HY-163904 (S,R,R)-VH032-CO-C3-CONH-C2-PEG3-OH / Unkown
HY-163930 (S,R,S)-AHPC-CO-cyclohexane-C2 / Unkown
HY-163986 Pomalidomide-C2-NHCO-C6 / Unkown
HY-164210 DBCO-PEG2-C2-acid / Unkown
HY-164212 DBCO-PEG1-OH / Unkown
HY-164909 PZ-3022 / Unkown
HY-165064 C2 L-Erythro ceramide (d18:1/2:0) Inducer / Unkown
HY-167810A Cyclosporin A Acetate-13C2,d4 / Unkown
HY-167906S Hexadecyl 2-((4-Nitrophenyl)thio)acetate-13C2 / Unkown
HY-168019 (S,R,S)-AHPC-PEG2-C2-boc / Unkown
HY-168298 Lenalidomide-6-F-piperidine-C2-Pip-C-COOH / Unkown
HY-168312 Thalidomide-NH-C2-2-azaspiro[3.3]heptane / Unkown
HY-168388 Piperidine-C2-piperazine-Boc / Unkown
HY-168389 Thalidomide-piperidine-C2-piperazine-Boc / Unkown
HY-168724 Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH Degrader / Unkown
HY-169082 JQ-1 (carboxylic acid)-NH-C2-NH-COOH / Unkown
HY-169141 BIIB021-NH-C2-piperidine-CO-Me / Unkown
HY-169150A JQ-1 carboxylic acid-PEG3-C2-NH2 hydrochloride / Unkown
HY-169236 COOH-C-PEG2-NHCO-C2-COOH / Unkown
HY-169237 Pomalidomide-C2-CONH-PEG2-C-COOH / Unkown
HY-169364 2-Methylbiphenyl-oxadiazole-NH-Ph-NH-PEG3-C2-NH-Boc Ligand / Unkown
HY-169385 ATC-324 Degrader / Unkown
HY-169395 (S,R,S)-AHPC-CO-PEG-C2-iodine / Unkown
HY-169397 Thalidomide-NH-CH2-CONH-C2-PEG-bromine / Unkown
HY-169433 Naph-Se-TMZ Inhibitor / Unkown
HY-169437 Nitro-Naphthalimide-C2-acylamide / Unkown
HY-169438 NNISC-2 / Unkown
HY-169480 Lipid C2 / Unkown
HY-170691 hAChE/hBuChE-IN-1 Inhibitor / Unkown
HY-170867 Nrf2/HO-1 activator 3 / Unkown
HY-172117 Boc-methylglycine-C2-bromine / Unkown
HY-172126 JQ-1 (carboxylic acid)-NH-C2-NH-AMPRO-222 / Unkown
HY-172145 Thalidomide-O-CH2-CO-NH-C2-PEG2-NH-Boc / Unkown
HY-172823 NH2-C2-PEG8-Succinamic acid / Unkown
HY-172902 RNA binder 1 / Unkown
HY-172951 Antitrypanosomal agent 23 Inhibitor / Unkown
HY-173132 AKR1Cs-IN-1 / Unkown
HY-173409 AR antagonist 11 / Unkown
HY-173520 EGFR/HDAC-IN-1 Inhibitor / Unkown
HY-17416AS1 Guanfacine-15N3,13C2 Agonist / Unkown
HY-174235 Thalidomide-OCH2-amide-PEG2-C2-Boc / Unkown
HY-174379 KRAS IN-44 / Unkown
HY-174861 (S,R,S)-AHPC-CO-C2-PEG-NHCO-C2-COOH / Unkown
HY-174863 Pomalidomide-C2-PEG-NHCO-C2-COOH / Unkown
HY-174875 (S,R,S)-AHPC-CO-C2-phenylboronic acid / Unkown
HY-17530S Aldicarb sulfone-13C2,d3 Inhibitor / Unkown
HY-175640 Troponin-IN-1 Inhibitor / Unkown
HY-175823 1,4-Naphthoquinone-NH-C2-NH-Trolox Inhibitor / Unkown
HY-175898 CBP/EP300 ligand-1 / Unkown
HY-176182 Br-C2-PEG3-OTs Chemical / Unkown
HY-176188 Lenalidomide-5-Br-amide-C2-Br / Unkown
HY-176202 TLR7/8 agonist 12-PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC / Unkown
HY-176240 FBnG-amino-PEG3-C2-azido Inducer / Unkown
HY-176383 PEG3-amide-C2-COOH / Unkown
HY-176384 Thalidomide-PEG3-amide-C2-COOH / Unkown
HY-176389 KB02-amide-PEG2-C2-acid / Unkown
HY-176536 (S,R,S)-AHPC-amide-PEG5-C2-azide / Unkown
HY-176726 ZnPc-amide-PEG3-C2-NH2 Inducer / Unkown
HY-176896 NHS-C2-(C-acid)-N-bis(C-Py-m-acid) / Unkown
HY-177347 RSK2-IN-6 Inhibitor / Unkown
HY-177823 C2NP sodium / Unkown
HY-178518 Thalidomide-C1-O-CO-C2-Piperazine-CO-C1-Azacyclohexane-C1-Piperazine / Unkown
HY-178721 Lithocholic amide-C2-N(didecane) Inhibitor / Unkown
HY-178759 DHFR-IN-5-amino-PEG3-C2-azido / Unkown
HY-178856 OC-C2-Cholesterol Inhibitor / Unkown
HY-179168 Thalidomide-C4-N2-C2-N3 Ligand / Unkown
HY-179375 LCI133 Inhibitor / Unkown
HY-179491 OTOP1-IN-1 Inhibitor / Unkown
HY-179627 STING agonist-49-CO-C2-mal / Unkown
HY-179628 STING agonist-49-CO-C2-mal-Cys / Unkown
HY-179629 PAB-Ala-Val-CO-C2-mal / Unkown
HY-179658 β-D-Glu-benzylalcohol-di(amide-C2)-mal / Unkown
HY-179659 STING agonist-49-β-D-Glu-benzylalcohol-di(amide-C2)-mal / Unkown
HY-179660 STING agonist-49-PAB-Ala-Val-CO-C2-mal / Unkown
HY-180575 LCB-2122 / Unkown
HY-180645 Prostaglandin C2 / Unkown
HY-180906 (S,R,S)-AHPC-C2-PEG3-NH2 / Unkown
HY-180953 Fmoc-NH-C2-diphosphate-dexamethasone / Unkown
HY-180978 H2N-PEG3-C2-Trizole-C3-COOH / Unkown
HY-180980 H2N-PEG4-C2-Trizole-C3-COOH / Unkown
HY-181118 Dexamethasone phosphate-C2-NH2 / Unkown
HY-181469 C2 Adamantanyl glucosylceramide (d18:1/2:0) Inhibitor / Unkown
HY-181542 SG-55 / Unkown
HY-181693 CCW16-C2-Boc / Unkown
HY-181736 Pomalidomide-C2-piperazine-Boc / Unkown
HY-181785 Influenza A virus-IN-18 Inhibitor / Unkown
HY-181905 (S,R,S)-AHPC-Me-C2-piperazine / Unkown
HY-182337 (S)-Pomalidomide-PEG1-C2-acid / Unkown
HY-182460 Gambogin Inhibitor / Unkown
HY-182539 DD04107 Modulator / Unkown
HY-182805 6-Dehydroxy-demethylation-α-Amanitin-OH-PAB-Ala-Val-CO-C2-mal / Unkown
HY-182806 Demethylation-desulfuration-α-Amanitin-OH-PAB-Ala-Val-CO-C2-mal / Unkown
HY-182813 MC-amide-C2-amide-(β-D-GlcUA)-amide-PEG1-CH2-CC-885 / Unkown
HY-183440 Amine-C2-piperazine-C4-OH / Unkown
HY-183442 ALK5 ligand-1-amine-C2-piperazine-C4-OH Ligand / Unkown
HY-183987 ZINC000002107582 / Unkown
HY-184481 DHPT-PEG2-C2-NH2 Ligand / Unkown
HY-184522 TPA(bi(Tos))-γ-Glu(PEG23)-Gly-Gly-Gly-C2-NH-PNU-159682 / Unkown
HY-184672 Thalidomide-NH-C2-NH-C5-NH2 / Unkown
HY-184928 S34-1040 Inhibitor / Unkown
HY-187094 7rh-C2-O-Boc Ligand / Unkown
HY-34628S2 Tri-O-acetyl-D-glucal-13C-2 / Unkown
HY-40171S NH2-C2-NH-Boc-d4 / Unkown
HY-403978S Benzamide-C6-N-Boc-C2-amide-phenol-d5 / Unkown
HY-48394A Bis-S-C2-N(N-Me)-C2-OH dihydrochloride / Unkown
HY-77956S2 Thyminose-13C-2 / Unkown
HY-90009AS Tadalafil-13C2,d3 / Unkown
HY-90009AS1 Tadalafil-13C2,d3-1 / Unkown
HY-B0101S1 Fluconazole-13C2,15N Inhibitor / Unkown
HY-B0141S5 Estradiol-13C2 Agonist 98.72% Unkown
HY-B0149S3 Tranexamic acid-13C2,15N / Unkown
HY-B0234S3 Estrone-13C2 Agonist / Unkown
HY-B0283S1 Acipimox-13C2,15N2 / Unkown
HY-B0389S22 D-Glucose-13C2,d2 / Unkown
HY-B0389S37 D-Glucose-13C2-6 / Unkown
HY-B0389S39 D-Glucose-13C2-8 / Unkown
HY-B0400S3 D-Sorbitol-13C-2 / Unkown
HY-B0495S3 Lamotrigine-13C2,15N / Unkown
HY-B0495S6 Lamotrigine-13C2,15N2,d3 / Unkown
HY-B0508S1 Ornidazole-13C2,15N2 Inhibitor / Unkown
HY-B0523S Anagrelide-13C2,15N,d2 / Unkown
HY-B1118S1 Secnidazole-13C2, 15N2 Inhibitor / Unkown
HY-B1640S Ethacrynic acid-13C2,d5 / Unkown
HY-B1773AS2 Sodium propionate-13C2 / Unkown
HY-B1842S Fluroxypyr-13C2 / Unkown
HY-B1912S1 Amidosulfuron-13C2,d6 / Unkown
HY-CE00156 (2S)-Pristanoyl-CoA / Unkown
HY-CE00612 2'-(5''-Phosphoribosyl)-3'-dephospho-CoA / Unkown
HY-CE00614 2'-(5-Triphosphoribosyl)-3'-dephospho-CoA / Unkown
HY-CE02036S Tropoyl-CoA-13C2 / Unkown
HY-D0017S1 Dansyl chloride-13C2 / Unkown
HY-D1551 10-(4-(Bis(2-hydroxyethyl)amino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / Unkown
HY-D3483 AF660 C2 Maleimide / Unkown
HY-D3572 AF430 C2 Maleimide / Unkown
HY-D3583 AF647 C2 Maleimide / Unkown
HY-E71077 (5R)-Carbapenem-3-carboxylate synthase / Unkown
HY-E71084 (R)-2-Haloacid dehalogenase / Unkown
HY-E71084A 2-Haloacid dehalogenase (configuration-inverting) / Unkown
HY-E71084B 2-Haloacid dehalogenase (configuration-retaining) / Unkown
HY-E71453C 23S rRNA (adenine2503-C2)-Methyltransferase / Unkown
HY-I0400S2 N-Acetylneuraminic acid-13C-2 / Unkown
HY-I0626S Cytosine-13C2,15N3 / Unkown
HY-N0059S2 D-arabinose-13C-2 / Unkown
HY-N0376R Liquiritin (Standard) / Unkown
HY-N0379S7 D-Mannose-13C-2 / Unkown
HY-N0602R Ginsenoside Rg2 (Standard) Inhibitor / Unkown
HY-N0666S7 L-Aspartic acid-1,4-13C2,15N Agonist / Unkown
HY-N10595 Ladanetin-6-O-β-(6′′-O-acetyl)glucoside / Unkown
HY-N10642 Pedaliin 6''-acetate / Unkown
HY-N10869 Pseudolaric acid C2-O-β-D-glucoside / Unkown
HY-N1150S4 Thymidine-13C-2 / Unkown
HY-N12156 Ajugasterone C 2-acetate / Unkown
HY-N12297 Ciwujianoside C2 Activator / Unkown
HY-N12447 C-2′-Decoumaroylaloeresin G / Unkown
HY-N1420AS2 Rhamnose-13C-2 monohydrate 99.0% Unkown
HY-N1428S2 Citric acid-13C2 / Unkown
HY-N1480S2 (-)-Fucose-13C-2 / Unkown
HY-N1517A (Rac)-Ganoderic acid C2 Inhibitor / Unkown
HY-N15704 Cassiaside C2 Inhibitor / Unkown
HY-N15984 18:1-12:0 Biotin PC / Unkown
HY-N16330 14:0-6:0(C2 NBD) PI(4,5)P2 TEA / Unkown
HY-N16833 Apigenin 6-C-(2-O-feruloyl)glucoside 8-C-glucoside / Unkown
HY-N3231 Murraol Inhibitor / Unkown
HY-N3671 Cycloshizukaol A / Unkown
HY-N3686S2 D-Arabitol-13C-2 Activator / Unkown
HY-N6625S Chlorothalonil-13C2 Inhibitor / Unkown
HY-N6910 Pseudolaric Acid C2 99.17% Unkown
HY-N7092S3 D-Fructose-13C2 98.0% Unkown
HY-N7394 Galbacin Activator / Unkown
HY-N7398S 2-Pentylfuran-13C2 / Unkown
HY-P0073S1 Tyr-{Gly-13C2,15N}-Gly-Phe-Met-OH TFA / Unkown
HY-P0073S2 Tyr-Gly-{Gly-13C2,15N}-Phe-Met-OH TFA / Unkown
HY-P0206S1 RPP-(Gly-13C2,15N)-FSPFR TFA / Unkown
HY-P10053 sPLA2-IIA Inhibitor Inhibitor / Unkown
HY-P10910 Vensemaglutide Agonist / Unkown
HY-P11127 MBP (111-129) / Unkown
HY-P11344S LLIYFASQSISGIPDR-13C2,15N / Unkown
HY-P11783 Surfactin C2 Inhibitor / Unkown
HY-P11824 CoA-C2-SGRGK-cCPP Inhibitor / Unkown
HY-P1389S Neuropeptide S (human)-13C2,15N / Unkown
HY-P2799I Creatine Kinase BB (CK-BB), human brain / Unkown
HY-P2889A Pyranose Oxidase, E. coli / Unkown
HY-P6176 JLB2-110c Inhibitor / Unkown
HY-R00539 hsa-miR-30c-2-3p mimic / Unkown
HY-R00539A hsa-miR-30c-2-3p agomir / Unkown
HY-RI00539 hsa-miR-30c-2-3p inhibitor / Unkown
HY-RI00539A hsa-miR-30c-2-3p antagomir / Unkown
HY-RS00535 AKR1C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01199 ATP2C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01227 ATP6V1C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01738 C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01740 C2CD3 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01741 C2CD5 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01742 C2orf69 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS05907 GTF3C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS05968 H3C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS05975 H4C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS06265 HNRNPC Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS09538 NR2C2AP Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS09547 NR3C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS09548 Nr3c2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS09549 Nr3c2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS09609 NT5C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10512 Pik3c2a Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10513 Pik3c2a Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10514 PIK3C2B Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10515 Pik3c2b Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10516 Pik3c2b Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10517 PIK3C2G Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10518 Pik3c2g Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS10519 Pik3c2g Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS14017 SULT1C2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W006057AS3 Sodium 3-methyl-2-oxobutanoate-13C2,d4 / Unkown
HY-W009411S Dansyl hydrazine-13C2 / Unkown
HY-W010042S2 L-Glucose-13C-2 / Unkown
HY-W010452S2 3-Hydroxybutyric acid-13C2 sodium / Unkown
HY-W012684S Ethane-1,2-diamine-13C2 dihydrochloride / Unkown
HY-W013061S5 Propane-1,2,3-triyl tripalmitate-13C2 / Unkown
HY-W013636S4 2-Ketoglutaric acid-13C2 Inhibitor / Unkown
HY-W014531S 2,6-Dichloro-4-nitrophenol-13C6 / Unkown
HY-W015466S1 Acetylvaline-13C2 / Unkown
HY-W017072S 1-Dodecene-1,2-13C2 / Unkown
HY-W017522S6 Adipic acid-13C2 Inhibitor / Unkown
HY-W018772S16 D-Ribose-1,2-13C2 / Unkown
HY-W018772S3 D-Ribose-13C-2 / Unkown
HY-W019796 Cbz-NH-PEG4-C2-acid / Unkown
HY-W035903S Ethanolamine-13C2 hydrochloride 98% Unkown
HY-W040028 Cartap hydrochloride Inducer / Unkown
HY-W040240S2 L-(-)-Sorbose-13C-2 / Unkown
HY-W042357S3 Ac-rC Phosphoramidite-13C2,d1 / Unkown
HY-W048482S rU Phosphoramidite-13C2,d1 / Unkown
HY-W068212S 16-Hydroxyhexadecanoic acid-13C2 / Unkown
HY-W074977S 2,6-Dibromo-4-nitrophenol-13C6 / Unkown
HY-W096111A Trt-PEG4-C2-acid hydrate / Unkown
HY-W096132 Dimethylamino-PEG2-C2-NH2 / Unkown
HY-W099580S Hexadecane-1,2-13C2 / Unkown
HY-W100312S o-Toluidine-13C6 hydrochloride / Unkown
HY-W1049085 mPEG1000-SS / Unkown
HY-W1049085A mPEG5000-SS / Unkown
HY-W1049085B mPEG10000-SS / Unkown
HY-W1049085C mPEG20000-SS / Unkown
HY-W1049085D mPEG40000-SS / Unkown
HY-W1049085E mPEG2000-SS / Unkown
HY-W1049085H mPEG-SS (MW 3400) / Unkown
HY-W1050064 4-(5,5-Difluoro-1,3,7,9-tetramethyl-5H-4lambda4,5lambda4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-10-yl)benzene-1,2-diamine / Unkown
HY-W112240 5,5-Difluoro-1,3,7,9-tetramethyl-10-phenyl-2,8-di(pyridin-4-yl)-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / Unkown
HY-W1125030S Ethyl acetoacetate-13C2-1 / Unkown
HY-W112589 2,8-Dibromo-5,5-difluoro-1,3,7,9-tetramethyl-10-(pyridin-4-yl)-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / Unkown
HY-W112590 2,8-Bis(4-(diphenylamino)phenyl)-5,5-difluoro-1,3,7,9-tetramethyl-10-phenyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / Unkown
HY-W112728 10-(4-Chlorophenyl)-5,5-difluoro-2,8-diiodo-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / Unkown
HY-W112729 10-(4-Chlorophenyl)-5,5-difluoro-1,3,7,9-tetramethyl-5H-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-4-ium-5-uide / Unkown
HY-W124385 5,5-Difluoro-1,3-dimethyl-5H-5lambda4,6lambda4-dipyrrolo[1,2-c:2',1'-f][1,3 / Unkown
HY-W124438 4-(5,5-Difluoro-1,3,7,9-tetramethyl-5H-4l4,5l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinin-10-yl)benzene-1,2-diol / Unkown
HY-W190793 Hydroxy-PEG8-C2-methyl ester / Unkown
HY-W338294S1 2'-Deoxycytidine-13C-2 monohydrate / Unkown
HY-W440881A DSPE-PEG3400-C2-DBCO sodium / Unkown
HY-W584529 VH032-C2-NH-Boc / Unkown
HY-W584532 VH032-O-C2-NH-Boc / Unkown
HY-W588192S 1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone-13C2,d4 / Unkown
HY-W590667 C2 Ceramide-1-phosphate / Unkown
HY-W654190 Fipronil sulfone-13C2,15N2 / Unkown
HY-W706737 N-Deschlorobenzoyl indomethacin-d3 / Unkown
HY-W709340 N-Boc-S-Bzl-L-Cys-Gly-OBzl-13C2,15N / Unkown
HY-W721606 Chlorantraniliprole-d6 / Unkown
HY-W747168 Ethyl Vinyllactate-13C2,d3 / Unkown
HY-W747216 2,4-Dichloro-5-methylpyrimidine-15N2,13C / Unkown
HY-W747218 2-Chloro-5-methylpyrimidin-4-amine-15N2,13C / Unkown
HY-W747751 Sorbic acid-13C2 / Unkown
HY-W747821 2,5,6-Triaminopyrimidin-4(3H)-one-13C2,15N / Unkown
HY-W747877 Methyl 2-aminoacetate hydrochloride-13C2,15N / Unkown
HY-W747965 8-Bromoguanosine-13C2,15N / Unkown
HY-W747970 2’,3’,5’-Tri-O-acetyl guanosine-13C2,15N / Unkown
HY-W747971 N2-Acetyl-O6-diphenylcarbamoylguanine-13C2,15N / Unkown
HY-W747973 N2,9-Diacetylguanine-13C2,15N / Unkown
HY-W748002 a-Methyl-2-piperidinemethanol-13C2 / Unkown
HY-W748285 2-Octanamidoacetic acid-13C2,15N / Unkown
HY-W748626 Acetic acid, 2-bromo-, hexadecyl ester-13C2 / Unkown
HY-W750238 Scoparone-13C2,d6 / Unkown
HY-W750530 Sodium 1H,1H,2H,2H-perfluoro hexanesulfonate-13C2 / Unkown
HY-W750531 Sodium 1H,1H,2H,2H-perfluoro octanesulfonate-13C2 / Unkown
HY-W751275 Ractopamine-13C2 Agonist / Unkown
HY-W751343 Perfluoro-n-tetradecanoic acid-13C2 / Unkown
HY-W751382 2H-Perfluoro-2-decenoic acid-13C2 / Unkown
HY-W753207 Porphobilinogen-13C2,15N / Unkown
HY-W753569 Octopamine (Acetic Acid)-13C2,15N / Unkown
HY-W754052 N-Butyrylglycine-13C2,15N / Unkown
HY-W754053 N-(2-Methylbutyryl)glycine-13C2,15N / Unkown
HY-W754054 Propionylglycine (Standard)-13C2,15N / Unkown
HY-W754548 Glycocholic acid-13C2,d4 / Unkown
HY-W755720 Tiglyl Glycine-13C2,15N Methyl Ester / Unkown
HY-W756792 1H,1H,2H,2H-Perfluorodecanesulfonic acid-13C2 sodium / Unkown
HY-W759458 N-Phthaloylglycine-13C2,15N / Unkown
HY-W759724 4-(Dimethylamino)phenacyl bromide-13C2 / Unkown
HY-W765303 N-Pivaloylglycine-13C2,15N / Unkown
HY-W765357 Glycine-13C2,15N p-Toluenesulfonate / Unkown
HY-W765992 N-Boc-erythro-sphingosine-13C2,d2 / Unkown
HY-W765997 Didanosine-13C2,15N / Unkown
HY-W766130 Ethisterone-13C2 / Unkown
HY-W766136 Aprepitant Impurity 9-13C2,d2 / Unkown
HY-W766769 Cyproterone Acetate-13C2,d3 Antagonist / Unkown
HY-W767035 O6-Benzyl-N2,3-etheno Guanosine-13C2,d1 / Unkown
HY-W767285 6-Amino-5-nitrosouracil-13C2 / Unkown
HY-W767601 (3S,6S)-3,6-Dimethyl-1,4-dioxane-2,5-dione-13C2 / Unkown
HY-W768057 Acetamide-13C2,15N / Unkown
HY-W768168 N-Acetyl-D-neuraminic Acid-13C2 / Unkown
HY-W768178 2-Amino-2-deoxyglucose hydrochloride-13C2 / Unkown
HY-W768188 (2r,4r)-Pentane-1,2,3,4,5-pentaoll-13C2 / Unkown
HY-W768220 D-Fructose-1,2-13C2 / Unkown
HY-W768245 a-D-Galactose-1,2-13C2 1-phosphate potassium / Unkown
HY-W768482 2-Amino-6-hydroxypyrimidin-4(1H)-one-13C2 / Unkown
HY-W768491 3',5'-Di-O-benzyl Entecavir-13C2,15N / Unkown
HY-W768637 N-(3-Indolylacetyl)glycine-13C2,15N / Unkown
HY-W768772 Fluroxypyr-13C2,d2 / Unkown
HY-W768963 2-(1-Cyanoethyl)indole-13C2,15N / Unkown
HY-W769077 N-Valerylglycine-13C2,15N / Unkown
HY-W769079 N-Isovaleroylglycine-13C2,15N / Unkown
HY-W769081 Tiglyl Glycine-13C2,15N / Unkown
HY-W769169 N-Isobutyrylglycine-13C2,15N / Unkown
HY-W769171 Suberylglycine-13C2,15N / Unkown
HY-W769723 3-Hydroxyhippuric acid-13C2,15N / Unkown
HY-W769991 Lactate sodium-13C2 / Unkown
HY-W770677 9-Carboxymethoxymethylguanine-13C2,15N / Unkown
HY-W771062 8-Aminoguanosine-13C2,15N / Unkown
HY-W771063 8-Aminoguanine-13C2,15N / Unkown
HY-W777037 2,3-Dichlorobenzamidyl Guanidine-13C2 / Unkown
HY-W777079 Valdecoxib-13C2,15N / Unkown
HY-W777099 N-Cbz-O-Bzl-L-Glu-S-Bzl-L-Cys-Gly[13C2,15N]-OBzl / Unkown
HY-W777154 Zoledronic acid-15N2,13C2 / Unkown
HY-W777297 Lapatinib-13C2,15N Ditosylate / Unkown
HY-W777329 (4E)-4-Octenedioic acid-13C2 / Unkown
HY-W777809 Guanine-13C2,15N / Unkown
HY-W777833 Ethyl 2-(6-nitro-2,3-dichlorobenzyl)glycine-13C2 / Unkown
HY-W778114 Guanine-13C2,7-15N / Unkown
HY-W778152 O,O-Dimethyl Phosphorothionate ammonium-13C2 / Unkown
HY-W778162 Phenanthrene-13C2 / Unkown
HY-W778203 Glycolic acid-13C2 / Unkown
HY-W778257 2-Amino-4,6-dichloropyrimidine-13C2 / Unkown
HY-W778297 5,6-Diamino-4-thiouracil-13C2 / Unkown
HY-W778300 Sodium 2-cyanoacetate-13C2 / Unkown
HY-W778335 Dimethyl Phthalate-13C2 / Unkown
HY-W778362 4-Chloro kynurenine-13C2,15N / Unkown
HY-W778393 cis-Tranexamic acid-13C2,15N / Unkown
HY-W778493 5-Ethyl-3,4-dihydro-2H-pyrrole-13C2 / Unkown
HY-W778716 2-(1-Ethoxyethylidene)malononitrile-13C2 / Unkown
HY-W778771 Benz[a]anthracene-7-acetic Acid-13C2 / Unkown
HY-W778772 Benz[a]anthracene-7-acetonitrile-13C2 / Unkown
HY-W778790 Ethyl 2-formamido-3-hydroxyacrylate-13C2 / Unkown
HY-W778791 N-Formylglycine ethyl ester-13C2 / Unkown
HY-W779008 2-Hydroxyacetaldehyde-13C2 / Unkown
HY-W779018 Xylose-13C2 / Unkown
HY-W779191 MeIQx-13C / Unkown
HY-W779386 N-Acetylglycine-13C2,15N / Unkown
HY-W779404 Ribavirin-13C2 / Unkown
HY-W779904 H-Gly-OBzl.TosOH-13C2,15N / Unkown
HY-W781971 Estradiol 17-Benzoate-13C2 / Unkown
HY-W782446 Dimethyl sulfoxide-13C2 / Unkown
HY-W783407S2 Ac-rG Phosporamidite-13C2 / Unkown
HY-W856224 5,5-Difluoro-1,3,7,9,10-pentamethyl-2,8-di(pyridin-4-yl)-5H-4l4,5l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinine / Unkown
HY-W877850 Mal-C5-N-bis(PEG2-C2-acid) 96.25% Unkown
HY-W957364 Pomalidomide-C2-Br / Unkown
HY-Y0219S 1,2,4-Triazole-13C2,15N3 / Unkown
HY-Y0262BS Oxalic Acid-13C2 disodium 98.15% Unkown
HY-Y0304S2 Dibutyl phthalate-13C2 / Unkown
HY-Y0338AS Poly ethylene glycol-13C2 / Unkown
HY-Y0383S2 Dimethyl terephthalate-13C2-1 / Unkown
HY-Y0418S2 Dulcite-13C-2 / Unkown
HY-Y0677S Carbethoxymethyldiethyl phosphonate-C13 / Unkown
HY-Y0946S1 Acetamide-13C2 / Unkown
HY-Y0989S2 Acetophenone-13C2 / Unkown
HY-Y1088S Hydrocinnamic acid-2,3-13C2 / Unkown
HY-Y1093S Ethyl acetoacetate-13C2 / Unkown
HY-Y1250S5 Fmoc-Gly-OH-13C2 Inhibitor / Unkown
HY-Z2862S Entecavir-13C2,15N-1 Inhibitor / Unkown
HY-100043S 2-Ethyl-3,5-dimethylpyrazine-13C2 / Unkown
HY-10218S1 Everolimus-13C2,d4 / Unkown
HY-10285S2 Saxagliptin-13C2 Inhibitor / Unkown
HY-10466S1 Daclatasvir-13C2,d6 Inhibitor / Unkown
HY-108491S N,N-Dimethylsphingosine-13C2 / Unkown
HY-111095S3A D-(-)-Lactic acid-13C-2 sodium / Unkown
HY-114457 Phosphatidylinositol 4,5-bisphosphate Substrate / Unkown
HY-118560S Tricyclodecenyl acetate-13C2 / Unkown
HY-119799 UK-500001 Inhibitor / Unkown
HY-124273 C2 L-threo Ceramide (d18:1/2:0) / Unkown
HY-124432 CRT0093964 Inhibitor / Unkown
HY-125571 A 74704 Inhibitor / Unkown
HY-126830 Antifolate C2 / Unkown
HY-129252 Prothracarcin Inhibitor / Unkown
HY-130155 AMPK activator C2 Activator / Unkown
HY-132223 LH1306 Inhibitor / Unkown
HY-133359 Cbz-NH-PEG24-C2-acid / Unkown
HY-133360 Cbz-NH-PEG36-C2-acid / Unkown
HY-133471 Fmoc-NH-PEG3-C2-NH2 / Unkown
HY-134682A Fmoc-NH-PEG5-C2-NH2 hydrochloride 98.98% Unkown
HY-135928 Biotin-C2-S-S-pyridine / Unkown
HY-140157 N-Me-N-bis(PEG4-C2-Boc) / Unkown
HY-140337 Ph-Bis(C1-N-(C2-NH-Boc)2) / Unkown
HY-143784S C14 Benzalkonium-1 acid-13C2,d11 chloride / Unkown
HY-144348S N-[4-(2-Pyridinyl)benzoyl]glycine-13C2,15N / Unkown
HY-15121S1 L-Theanine-13C2,15N2 / Unkown
HY-152040S Tenuazonic acid-(acetyl-13C2) (mixture of diastereomers) in methanol / Unkown
HY-156326S (3E,5E)-Octadien-2-one-13C2 / Unkown
HY-156326S1 (3E,5Z)-Octadien-2-one-13C2 / Unkown
HY-158343 Thalidomide-NH-PEG2-C2-CH2 / Unkown
HY-158918 4-CF3-TPP-DC / Unkown
HY-160069 Fmoc-Gly-Gly-Gly-NH-PEG4-C2-COOH / Unkown
HY-160235 Pomalidomide-C2-amide-C5-azide / Unkown
HY-161773 HL389-NHC2-PEG3-C2NH / Unkown
HY-164043 (S,R,S)-AHPC(Me)-amido-C2-acid 95.05% Unkown
HY-164391 Pomalidomide-C2-amide-C4-Br / Unkown
HY-16504S Treprostinil-13C2-d1 Sodium Agonist / Unkown
HY-165072 C2 3'-Sulfo galactosylceramide (d18:1/2:0) / Unkown
HY-165691S Chlorothalonil Metabolite R611553-13C2,15N2 sodium salt / Unkown
HY-165694S 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate sodium-13C2,15N2 / Unkown
HY-165696S 2,4-Dicarbamoyl-3,5,6-trichlorobenzenesulfonate sodium-13C2,15N2 / Unkown
HY-166226 C2 Sphingomyelin (d18:1/2:0) / Unkown
HY-168244 TsO-C2-Piperidine-O-azetidine-CO-Ph-C2-OH / Unkown
HY-168297 Piperidine-C2-Pip-C-COOH / Unkown
HY-168723 Piperidine-C-Pip-C2-Pip-C2-OH / Unkown
HY-168870 OH-PEG3-C2-Succinamic acid-2-(Methylamino)ethanol / Unkown
HY-170315 Ethyne-C2-Pip-CO-Pip-Boc / Unkown
HY-170319 Lenalidomide-ethyne-C2-Pip-CO-Pip / Unkown
HY-171024 Cannabinol ethyl / Unkown
HY-174504 Human ZIC1 mRNA / Unkown
HY-176176S MDEKMLVLWVVALS(Gly-13C2,15N)IST / Unkown
HY-176390 Adamantan-C-amide-PEG2-C2-amine / Unkown
HY-176478 PAB-(PEG4-Me)-Cit-Val-PEG2-amide-C2-MC / Unkown
HY-178051 Antifungal agent 135 Inhibitor / Unkown
HY-180121 tBu-MTX-CO-NH-C2-O-C2-N3 / Unkown
HY-182145 Psoralen C2 phosphoramidite / Unkown
HY-182147 5'-Aldehyde-modifier C2 phosphoramidite / Unkown
HY-182225 Amino-modifier C2 dT / Unkown
HY-186088 DOTA-tris(t-Bu)ester-PEG3-C2-amine / Unkown
HY-187074 KB02-COO-NH-PEG2-C2-NH2 / Unkown
HY-201028 5'-C2-O-DMT-2'-F-5-MeO-U-3'-CE Phosphoramidite / Unkown
HY-201029 5'-C2-O-DMT-2'-F-1-Me-Pseudouridine-3'-CE phosphoramidite / Unkown
HY-201223 Chloroquine-C2 CE phosphoramidite / Unkown
HY-402409 5'-Amino-modifier C2-PEG2-TFA / Unkown
HY-76204S1 Glycine ethyl ester-13C2 hydrochloride / Unkown
HY-B0084S3 Dienogest-13C2,15N Agonist / Unkown
HY-B0214S3 Prednisone-13C2,d2 / Unkown
HY-B0554S1 Norethindrone-13C2 Agonist / Unkown
HY-B1258S Intermediate of tranexamic Acid-13C2,15N / Unkown
HY-B1290S3 2-Phenylethanol-13C2 Inhibitor / Unkown
HY-D3058 FITC-amide-C2 Lck inhibitor 2 Inhibitor / Unkown
HY-N0091S4 Hypoxanthine-13C2,15N-1 / Unkown
HY-N0215S15 DL-3-Phenylalanine-13C-2 / Unkown
HY-N0229S19 L-Alanine-1,2-13C2-1 / Unkown
HY-N0230S5 β-Alanine-13C / Unkown
HY-N0420S4 Succinic acid-13C2-2 / Unkown
HY-N11857 Gentamicin C2 Inhibitor / Unkown
HY-N14104 Cinatrin C2 Inhibitor / Unkown
HY-N14431 Salfredin C2 Inhibitor / Unkown
HY-N14459 Pluracidomycin C2 Inhibitor / Unkown
HY-N14705 2-Hydroxygentamicin C2 Inhibitor / Unkown
HY-N14709 Kibdelin C2 Inhibitor / Unkown
HY-N14844 Napyradiomycin C2 Inhibitor / Unkown
HY-N15125 1-Deamino-1-hydroxygentamicin C2 Inhibitor / Unkown
HY-N15167 Chlorophyll c2 / Unkown
HY-N2362S9 DL-Alanine-13C2,15N / Unkown
HY-N5199 4"-Demethylgentamicin C2 Inhibitor / Unkown
HY-N7125S Cinnamyl acetate-13C2 / Unkown
HY-N9484S Menthofuran-13C2 / Unkown
HY-P3448S1 Certepetide-13C2,15N Activator / Unkown
HY-RS17030 C2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS17438 Cfb Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20653 Sult1c2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21673 Nt5c2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS22687 Nr2c2 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23474 C2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24021 Akr1c2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS27164 Sult1c2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS28191 Nt5c2 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS29201 Nr2c2 Rat Pre-designed siRNA Set A / Unkown
HY-W001942S2 DL-2-Methylbutyric acid-13C2 / Unkown
HY-W006057AS Sodium 3-methyl-2-oxobutanoate-13C2,d1 99.9% Unkown
HY-W010392S1 Ethyl 2-methylbutanoate-13C2 / Unkown
HY-W010489S1 2-Phenylacetaldehyde-13C2 / Unkown
HY-W012864S2 (2S,3R)-2,3,4-Trihydroxybutanal-13C-2 99.4% Unkown
HY-W012998S1 2,3-Pentanedione-13C2 / Unkown
HY-W015307S 4-Ethyloctanoic acid-13C2 / Unkown
HY-W015604S 2,3-Diethyl-5-methylpyrazine-13C2 / Unkown
HY-W015824S6 L-Aspartic acid-13C-2 Agonist / Unkown
HY-W015883AS Fumaric acid2,3-13C2 disodium 99% Unkown
HY-W017018S1 L-Ornithine-1,2-13C2 hydrochloride / Unkown
HY-W020678S 2-Methylbutanal-13C2 / Unkown
HY-W092205 Fmoc-NH-CH2-PEG3-C2-NH2 hydrochloride / Unkown
HY-W096111 Trt-PEG4-C2-COOH / Unkown
HY-W102356S1 Phenethyl acetate-13C2 / Unkown
HY-W105988 Copper dihydroxide / Unkown
HY-W127515S trans-2,cis-6-Nonadienal-13C2 / Unkown
HY-W184476 NH2-PEG-C2-methanamine / Unkown
HY-W190779 Hydroxy-PEG7-C2-COOH / Unkown
HY-W343292S 2-Methylbutyl acetate-13C2 / Unkown
HY-W383171 Boc-pyrrolidine-Pip-C2-NH2 / Unkown
HY-W590667A C2 Ceramide-1-phosphate ammonium / Unkown
HY-W615166 Thalidomide-NH-C2-alkyne / Unkown
HY-W615173 NHS ester-C2-NHCO-C2-NHS / Unkown
HY-W653745 6-Thioguanine-13C2,15N / Unkown
HY-W654191 Fipronil detrifluoromethylsulfinyl-13C2,15N2 / Unkown
HY-W654304 Oxonic Acid -13C2,15N3 potassium salt hydrate / Unkown
HY-W654343 D-Erythro-sphingosine-1-phosphate-13C2,d2 / Unkown
HY-W748328 Ixazomib-13C2,15N / Unkown
HY-W766368 C6 Ceramide-13C2,d2 / Unkown
HY-W768398 Ethephon-13C2 / Unkown
HY-W777166 Aprepitant-13C2,d2 (Major) Inhibitor / Unkown
HY-W777583 2-[4-(1-Ethyl-1,4-dimethylpentyl)phenoxy]ethanol-13C6 / Unkown
HY-W778064 L-threo-Droxidopa-13C2,15N / Unkown
HY-W778142 Dimethyl Phosphate-13C2 sodium / Unkown
HY-W778154 O,O-Dimethyl dithiophosphate-13C2 ammonium Inhibitor / Unkown
HY-W778391 Bisphenol A-13C2 / Unkown
HY-W779002 alpha-D-glucose-13C2-1 / Unkown
HY-W779534 4,5-Dimethyl-3-hydroxy-2(5H)-furanone-13C2 / Unkown
HY-W779542 (2E,4E,6E)-2,4,6-Nonatrienal-13C2 / Unkown
HY-W793322 Cbz-NH-C2-PEG3-Br / Unkown
HY-W998277 Desamino lenalidomide-acetylene-C2-OH / Unkown
HY-W998294 E3 ligase Ligand PG-piperidine-C2-OH / Unkown
HY-W998314 (S,R,S)-AHPC-Me-CO-C2-COOH / Unkown
HY-Y0045S 2-Acetylthiazole-13C2 / Unkown
HY-B0627S1 Metformin-13C2 hydrochloride / Unkown
HY-Y0068S N-Acetyl-L-phenylalanine-13C2 / Unkown
Inhibitory Antibodies (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P990838 Anti-IL-12 p70 Antibody (20C2) Inhibitor 95.00% Unkown
HY-P990813 Anti-Mouse Nonclassical MHC Class I molecule Qa-1b Antibody (4C2.4A7.5H11) Inhibitor / Unkown
HY-P990834 Anti-MAGEC2/CT10 Antibody (LX-CT10.5) Inhibitor / Unkown
HY-P991745 Anti-Mouse CCR2 Antibody (C2Mab-6) Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Felis catus C2 VGNC VGNC:102387
Bos taurus C2 VGNC VGNC:53959
Mus musculus C2 MGD MGI:88226
Canis familiaris C2 VGNC VGNC:103663
Rattus norvegicus C2 RGD RGD:2231
Others C2 NCBI